These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9704143)

  • 1. [Urinary enzymes during some antiblastic chemotherapy protocols].
    Airoldi M; Pecchio F; Albanese F; Mastromatteo V; Gariboldi A; Negri L; Fazio M
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):399-405. PubMed ID: 9704143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary lysozyme, beta-2-microglobulin, and alpha-glucosidase during cisplatin therapy].
    Airoldi M; Pecchio F; Albanese F; Mastromatteo V; Gariboldi A; Di Costanzo G; Fazio M
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):392-8. PubMed ID: 9704142
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of localized lymphoma.
    Tanvetyanon T
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of metastatic breast cancer].
    Yahalom J; Biran S; Sulkes A
    Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastrointestinal lymphomas: results of multimodal therapy in 57 patients of one center].
    Kiene J; Sezer O; Rasche H; Klempa I
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():244-6. PubMed ID: 9101844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
    Kato H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA; Kruglova GV
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer agents. Unique protocol looks promising for lymphoma.
    TreatmentUpdate; 2003; 15(4):5-7. PubMed ID: 17216853
    [No Abstract]   [Full Text] [Related]  

  • 11. Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma.
    Dann EJ; Epelbaum R; Avivi I; Ben Shahar M; Haim N; Rowe JM; Blumenfeld Z
    Hum Reprod; 2005 Aug; 20(8):2247-9. PubMed ID: 15817583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
    Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F
    Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
    Ohmoto K; Tsuduki M; Yamamoto S
    Am J Gastroenterol; 2003 May; 98(5):1215-6; author reply 1217. PubMed ID: 12809863
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Lyman GH; Delgado DJ
    Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Kosmas C; Malamos NA; Antonopoulos MJ
    N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841319
    [No Abstract]   [Full Text] [Related]  

  • 18. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.
    Bermúdez A; Marco F; Conde E; Mazo E; Recio M; Zubizarreta A
    Haematologica; 2000 Aug; 85(8):894-5. PubMed ID: 10942955
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pancytopenia after viral infection in St. n. malignant lymphoma].
    Seifert B; Favre G
    Praxis (Bern 1994); 2003 Jan; 92(4):143-6. PubMed ID: 12632845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.